Penfluridol

This classification denotes a dopamine antagonist with the molecular formula C28H27ClF5NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 25TLU22Q8H, chemically known as 4-piperidinol, 4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-1-(4,4-bis(p-fluorophenyl)butyl)- but generally known as penfluridol, which bears US NIH Compound Identifier 33630. European Medicines Agency schedules Penfluridol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09664MIG. The term PENFLURIDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules penfluridol in its Anatomical Therapeutic Chemical (ATC) Classification. PENFLURIDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule penfluridol under HS 29333999 and SITC 51574. As of Q4 2014, PENFLURIDOL remains the US FDA Preferred Term for this commodity. Penfluridol bears US NLM identifiers UMLS ID C0030815 and NCI Concept Code C90843. SMILES: CLC1C(CC(C2(O)CCN(CC2)CCCC(C2CCC(F)CC2)C2CCC(F)CC2)CC1)C(F)(F)F.